Clinical Trial Update: Use of Hydralazine and Valproic Acid in Advanced Solid Tumor Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the combination of hydralazine and valproic acid in patients with advanced solid tumors, including lung cancer, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Hydralazine (hydralazine)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED